Differences in high dose antipsychotic prescriptions in patients with schizophrenia in asian countries/areas: Findings from the reap-ap study

Yong Chon Park, Shu Yu Yang, Mian Yoon Chong, Shigenobu Kanba, Norman Sartorius, Naotaka Shinfuku, Chay Hoon Tan, Seon Cheol Park

Research output: Contribution to journalArticlepeer-review

9 Citations (Scopus)

Abstract

The REAP-AP study recruited 3,746 patients with schizophrenia, in March and April 2016, from 71 centers in 15 Asian countries/terri-tories namely Bangladesh, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Myanmar, Pakistan, Singapore, Sri Lanka, Taiwan, Thailand and Vietnam. Our findings reveal a trend according to which high dose antipsychotic prescription is more prevalent in Eastern Asia (especially, Japan and Korea) than in other regions of Asia. This historical factor may be associated with our finding of an Eastern Asian preponderance of high dose antipsychotic prescription.

Original languageEnglish
Pages (from-to)1007-1008
Number of pages2
JournalPsychiatry Investigation
Volume15
Issue number10
DOIs
Publication statusPublished - 2018

All Science Journal Classification (ASJC) codes

  • Psychiatry and Mental health
  • Biological Psychiatry

Fingerprint

Dive into the research topics of 'Differences in high dose antipsychotic prescriptions in patients with schizophrenia in asian countries/areas: Findings from the reap-ap study'. Together they form a unique fingerprint.

Cite this